Most Cited Papers In Last Two Years

Open Access Review

Available online: 22 Nov 2022

Open Access Review

Caffeine, chocolate, and adenosine antagonism in Parkinson's disease

DOI: 10.20517/and.2022.24

Heinz Reichmann

Available online: 22 Nov 2022

Open Access Review

Available online: 17 Nov 2022

Open Access Review

Oxidative stress-mediated inflammation promotes the pathogenesis of amyotrophic lateral sclerosis

DOI: 10.20517/and.2022.26

Stanley H. Appel

Available online: 17 Nov 2022

Open Access Review

Available online: 18 Oct 2022

Open Access Review

Rat models of major neurodegenerative disorders

DOI: 10.20517/and.2022.19

Arianna Novati, ... Huu Phuc Nguyen

This article belongs to the Special Issue Topic: Animal Models of Different Species for Investigating Neurodegenerative Diseases

Available online: 18 Oct 2022

Open Access Perspective

Available online: 20 Sep 2022

Open Access Perspective

Ferroptotic cells augment T-cell activation and neuroinflammation

DOI: 10.20517/and.2022.17

Ying Xue, ... Weimin Wang

This article belongs to the Special Issue Topic: Ferroptosis in Neurological Disorders

Available online: 20 Sep 2022

Open Access Perspective

Available online: 20 Sep 2022

Open Access Perspective

Genome-edited rabbit, a prospective alternative model for neurological diseases

DOI: 10.20517/and.2022.15

Zhongtian Zhang, ... Zhanjun Li

This article belongs to the Special Issue Topic: Animal Models of Different Species for Investigating Neurodegenerative Diseases

Available online: 20 Sep 2022

Open Access Original Article

Available online: 25 Aug 2022

Open Access Original Article

Exploring the causal relationship between dietary macronutrients and neurodegenerative diseases: a bi-directional two-sample Mendelian randomization study

DOI: 10.20517/and.2022.12

Tao Wei

, ... Yi Tang

Available online: 25 Aug 2022

Open Access Review

Available online: 31 Jul 2022

Open Access Review

Genetically engineered pig models of neurological diseases

DOI: 10.20517/and.2022.13

Caijuan Li, ... Sen Yan

This article belongs to the Special Issue Topic: Animal Models of Different Species for Investigating Neurodegenerative Diseases

Available online: 31 Jul 2022

Open Access Review

Available online: 24 Jul 2022

Open Access Review

Modeling neurodegenerative diseases using non-human primates: advances and challenges

DOI: 10.20517/and.2022.14

Bang Li, ... Xiang-Yu Guo

This article belongs to the Special Issue Topic: Animal Models of Different Species for Investigating Neurodegenerative Diseases

Available online: 24 Jul 2022

Open Access Review

Available online: 21 Jul 2022

Open Access Review

Tau-targeting therapy in Alzheimer's disease: critical advances and future opportunities

DOI: 10.20517/and.2022.16

Yi Guo, ... Jun Tan

Available online: 21 Jul 2022

Open Access Original Article

Available online: 6 Jul 2022

Open Access Original Article

One-year self-reported neurological sequelae in older COVID-19 survivors

DOI: 10.20517/and.2022.10

Li Jiang, ... Ling-Ru Wang

This article belongs to the Special Issue Topic: COVID-19 Infection and Brain Diseases

Available online: 6 Jul 2022

Open Access Review

Available online: 12 Jun 2022

Open Access Review

Electroneurography abnormality in Parkinson's disease: a potential biomarker to help diagnosis

DOI: 10.20517/and.2022.04

Yiying Hu, ... Chunli Song

Available online: 12 Jun 2022

Open Access Clinical Observation

Available online: 29 May 2022

Open Access Clinical Observation

Olfactory and gustatory dysfunctions in patients with COVID-19 in Wuhan, China

DOI: 10.20517/and.2022.09

Li Zou, ... Zhentao Zhang

Available online: 29 May 2022

Open Access Original Article

Available online: 24 May 2022

Open Access Original Article

A sequential deposition of amyloid beta oligomers, plaques and phosphorylated tau occurs throughout life in the canine retina

DOI: 10.20517/and.2022.06

Umma Habiba, ... Mourad Tayebi

Available online: 24 May 2022

Open Access Original Article

Available online: 27 Apr 2022

Open Access Original Article

Selective expression of neurodegenerative diseases-related mutant p150^Glued in midbrain dopaminergic neurons causes progressive degeneration of nigrostriatal pathway

DOI: 10.20517/and.2022.07

Jia Yu, ... Huaibin Cai

Available online: 27 Apr 2022

Open Access Letter to Editor

Available online: 17 Apr 2022

Open Access Letter to Editor

Chronic intracerebroventricular administration is a reliable method in brain studies on monkeys

DOI: 10.20517/and.2022.02

Lin-Heng Zhang, ... Xin-Tian Hu

Available online: 17 Apr 2022

Open Access Review

Available online: 30 Mar 2022

Open Access Review

Influence of sleep disruption on protein accumulation in neurodegenerative diseases

DOI: 10.20517/and.2021.10

Xiying Wang

, ... Jiada Li

Available online: 30 Mar 2022

Open Access Review

Available online: 28 Mar 2022

Open Access Review

Recent developments in understanding brain aging: sex differences, mechanisms, and implications in diseases

DOI: 10.20517/and.2022.03

Jing Yang, ... Huan Ma

Available online: 28 Mar 2022

Open Access Review

Available online: 28 Jan 2022

Open Access Review

Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer’s disease

DOI: 10.20517/and.2022.05

Mei-Yun Tang, ... Pamela J. Lein

Available online: 28 Jan 2022

Open Access Review

Available online: 16 Jan 2022

Open Access Review

A novel neuroprotective cholinesterase-monoamine oxidase inhibitor for treatment of dementia and depression in Parkinson’s disease

DOI: 10.20517/and.2021.09

Wei Liu, ... Moussa B. H. Youdim

Available online: 16 Jan 2022

Open Access Perspective

Available online: 10 Aug 2021

Open Access Perspective

Interplay among norepinephrine, NOX2, and neuroinflammation: key players in Parkinson's disease and prime targets for therapies

DOI: 10.20517/and.2021.06

Qingshan Wang, ... Jau-Shyong Hong

Available online: 10 Aug 2021

Search Filter

Caffeine, chocolate, and adenosine antagonism in Parkinson's disease

Oxidative stress-mediated inflammation promotes the pathogenesis of amyotrophic lateral sclerosis

Rat models of major neurodegenerative disorders

Ferroptotic cells augment T-cell activation and neuroinflammation

Genome-edited rabbit, a prospective alternative model for neurological diseases

Exploring the causal relationship between dietary macronutrients and neurodegenerative diseases: a bi-directional two-sample Mendelian randomization study

Genetically engineered pig models of neurological diseases

Modeling neurodegenerative diseases using non-human primates: advances and challenges

Tau-targeting therapy in Alzheimer's disease: critical advances and future opportunities

One-year self-reported neurological sequelae in older COVID-19 survivors

Electroneurography abnormality in Parkinson's disease: a potential biomarker to help diagnosis

Olfactory and gustatory dysfunctions in patients with COVID-19 in Wuhan, China

A sequential deposition of amyloid beta oligomers, plaques and phosphorylated tau occurs throughout life in the canine retina

Selective expression of neurodegenerative diseases-related mutant p150^Glued in midbrain dopaminergic neurons causes progressive degeneration of nigrostriatal pathway

Chronic intracerebroventricular administration is a reliable method in brain studies on monkeys

Influence of sleep disruption on protein accumulation in neurodegenerative diseases

Recent developments in understanding brain aging: sex differences, mechanisms, and implications in diseases

Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer’s disease

A novel neuroprotective cholinesterase-monoamine oxidase inhibitor for treatment of dementia and depression in Parkinson’s disease

Interplay among norepinephrine, NOX2, and neuroinflammation: key players in Parkinson's disease and prime targets for therapies

Committee on Publication Ethics

Portico

Committee on Publication Ethics

Portico

Most Cited Papers In Last Two Years

Search Filter

Caffeine, chocolate, and adenosine antagonism in Parkinson's disease

Oxidative stress-mediated inflammation promotes the pathogenesis of amyotrophic lateral sclerosis

Rat models of major neurodegenerative disorders

Ferroptotic cells augment T-cell activation and neuroinflammation

Genome-edited rabbit, a prospective alternative model for neurological diseases

Exploring the causal relationship between dietary macronutrients and neurodegenerative diseases: a bi-directional two-sample Mendelian randomization study

Genetically engineered pig models of neurological diseases

Modeling neurodegenerative diseases using non-human primates: advances and challenges

Tau-targeting therapy in Alzheimer's disease: critical advances and future opportunities

One-year self-reported neurological sequelae in older COVID-19 survivors

Electroneurography abnormality in Parkinson's disease: a potential biomarker to help diagnosis

Olfactory and gustatory dysfunctions in patients with COVID-19 in Wuhan, China

A sequential deposition of amyloid beta oligomers, plaques and phosphorylated tau occurs throughout life in the canine retina

Selective expression of neurodegenerative diseases-related mutant p150Glued in midbrain dopaminergic neurons causes progressive degeneration of nigrostriatal pathway

Chronic intracerebroventricular administration is a reliable method in brain studies on monkeys

Influence of sleep disruption on protein accumulation in neurodegenerative diseases

Recent developments in understanding brain aging: sex differences, mechanisms, and implications in diseases

Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer’s disease

A novel neuroprotective cholinesterase-monoamine oxidase inhibitor for treatment of dementia and depression in Parkinson’s disease

Interplay among norepinephrine, NOX2, and neuroinflammation: key players in Parkinson's disease and prime targets for therapies

Committee on Publication Ethics

Portico

Committee on Publication Ethics

Portico

Selective expression of neurodegenerative diseases-related mutant p150^Glued in midbrain dopaminergic neurons causes progressive degeneration of nigrostriatal pathway